Title: Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse
Abstract: Galanin was recently demonstrated to be a neuropeptide in intrapancreatic nerves. In this study, the effects of galanin on basal and stimulated insulin and glucagon secretion in the mouse were investigated. Galanin, injected intravenously at dose levels ranging from 0.53 to 8.5 nmol kg ‐1 , markedly lowered basal plasma insulin levels and transiently increased basal plasma glucagon levels. Furthermore, galanin induced hyperglycaemia: plasma glucose levels were 11 ± 0.2 mmol l ‐1 2 min after injection of galanin (4.25 nmol kg ‐1 ) compared with 9.3 ± 0.3 mmol ‐1 in controls ( P < 0.001). Galanin also impaired the plasma insulin response to either glucose or the cholinergic agonist carbachol. Thus, galanin (4.25 nmol kg ‐1 ) inhibited the plasma insulin response to glucose by 65% ( P < 0.001), and that to carbachol by 85% ( P < 0.001). Moreover, glucose abolished the galanin‐induced plasma glucagon response. Also, galanin and carbachol exerted additive stimulatory effects on glucagon levels. It is concluded from this study in mice that galanin inhibits basal and stimulated insulin secretion, stimulates glucagon secretion, and induces hyperglycaemia. It is suggested that the intrapancreatic neuropeptide galanin is of importance in the regulation of both insulin and glucagon secretion.
Publication Year: 1987
Publication Date: 1987-03-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 68
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot